CAS: 579-56-6; Isoxsuprine Hydrochloride

该化合物是一种主要用作血管消毒器和管理诸如边缘血管疾病和某些种类子宫收缩等条件的药物化合物,被归类为乙型急性抗激剂,这意味着它可以刺激乙型亚虫受体,导致肌肉的放松和血管的放大.该化合物看起来像白色和脱白晶粉,在水中可溶解,适合各种配方,包括口服和可注射的制剂.盐酸异辛酸盐的分子重量相对较低,其特点是能够改善血液流动,特别是在极端地区.其药效效应可包括心率上升和子宫音下降,这在特定的临床情况下是有益的.与任何药物一样,在开药或使用异氧盐时,必须考虑潜在的副作用,抗药作用以及与其他药物的相互作用.

结构式图片

欧盟法规

ECHA物质C&L通报REACH预注册

合成工艺路线路线简述

    海关参考信息

    专利信息


    专利号:US-8354116-B2
    优先权日:2007-06-18
    标题 :Bifunctional synthetic molecules
    发明人:CARTER STEPHEN G; PATEL KANU; ZHU ZHEN; QIAO LIXIN
    权利人:BIOCHEMICS INC; CARTER STEPHEN G; PATEL KANU; ZHU ZHEN; QIAO LIXIN
    摘要:The synthesis and use of bifunctional molecules to improve the topical and transdermal delivery efficiency of various types of therapeutic agents or agents designed to promote the transdermal delivery of those therapeutic agents either into the skin tissue or into the systemic circulation. Three major classes of molecules are covalently joined as bifunctional substances; chemical vasodilators, passive dermal penetration enhancers and therapeutic or diagnostic drugs. Chemical vasodilators may be delivered into the skin to increasing the blood flow in a tissue that has compromised circulation or they may be used as part of a delivery vehicle to promote the delivery of the drug. Passive dermal penetration enhancers are those chemicals that promote the passive penetration of drugs and other chemicals through the stratum corneum and epidermis of the skin tissue. Drugs and diagnostic agents are the third group of chemicals that are candidates for the linkage of molecules.

    专利号:US-2014315720-A1
    优先权日:2012-10-24
    标 题 :Polysaccharide ester microspheres and methods and articles relating thereto
    发明人:FALLON DENIS G; GARRETT THOMAS S; KIZER LAWTON E; ZAZZARA KAREN L; COMBS MICHAEL T; JOHNSON RICHARD K; DEHART GARY
    权利人:CELANESE ACETATE LLC
    摘要:A method for producing a polysaccharide ester microsphere may include forming a polysaccharide ester product from a polysaccharide synthesis, wherein the polysaccharide ester product comprises a polysaccharide ester and a solvent; diluting the polysaccharide ester product, thereby yielding a polysaccharide ester dope; and forming a plurality of polysaccharide ester microspheres from the polysaccharide ester dope. Suitable polysaccharides may include, but are not limited to, starch, cellulose, hemicellulose, algenates, chitosan, and any combination thereof. Esters thereof may be organic esters (e.g., acetate and the like), inorganic esters (e.g., sulfonates and the like), or combinations thereof. Further, the solids conent of the polysaccharide ester dope, in some instances, may be greater than about 16 wt %.

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Hill JW, Thompson JF, Carter MB, Edwards BS, Sklar LA, Rosenberg GA. Identification of isoxsuprine hydrochloride as a neuroprotectant in ischemic stroke through cell-based high-throughput screening. PLoS One. 2014 May 7;9(5):e96761. doi: 10.1371/journal.pone.0096761. eCollection 2014.
    2: Costa W, Silva AL, Costa GR, Vidigal PV, Pereira FH. Analysis of effect isoxsuprine hydrochloride and nicotine in the Transverse Rectus Abdominis Myocutaneous flap (TRAM) in rats. Acta Cir Bras. 2015 Jul;30(7):497-502. doi: 10.1590/S0102-865020150070000008. doi: 10.1016/j.theriogenology.2014.01.031. Epub 2014 Jan 31. doi: 10.1007/s00784-012-0824-z. Epub 2012 Aug 15. doi: 10.14661/2015.1144-1149. eCollection 2015 Aug.
    6: Groot MJ, Lasaroms JJ, Van Hende J, Nielen MW. Veterinary treatment of cows with isoxsuprine for a caesarian section may temporarily lead to residues in hair of both cow and calf. Drug Test Anal. 2012 Jun;4(6):515-8. doi: 10.1002/dta.272. Epub 2011 Mar 5. doi: 10.1055/s-0031-1296305. doi: 10.1002/bmc.3284. Epub 2014 Jul 7. doi: 10.1016/j.theriogenology.2015.11.010. Epub 2015 Nov 22. doi: 10.1038/bjc.2012.580. Epub 2013 Jan 8.

    合成参考文献


    摘要:Toxicology and Applied Pharmacology., 1(579), 1959
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知